Drug Shortage Report for TEVA-LATANOPROST
| Report ID | 218963 |
| Drug Identification Number | 02254786 |
| Brand name | TEVA-LATANOPROST |
| Common or Proper name | LATANOPROST EYE DROP SOL'N |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | LATANOPROST |
| Strength(s) | 50MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 0.005% |
| ATC code | S01EE |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-02-07 |
| Estimated end date | 2024-12-20 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-03-21 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2024-03-21 | French | Compare |
| v7 | 2024-03-21 | English | Compare |
| v6 | 2024-02-29 | French | Compare |
| v5 | 2024-02-29 | English | Compare |
| v4 | 2024-02-22 | French | Compare |
| v3 | 2024-02-22 | English | Compare |
| v2 | 2024-02-08 | French | Compare |
| v1 | 2024-02-08 | English | Compare |
Showing 1 to 8 of 8